Synopsis
0
JDMF
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1440ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML;105MG/100ML;3.5GM/100ML (1920ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100...DOSAGE - EMULSION;INTRAVENOUS - 2.4%;20MG/100ML;6.8GM/100ML;68MG/100ML;124MG/100ML;170MG/100ML ;105MG/100ML;3.5GM/100ML (2400ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML ;147MG/100ML;3.9GM/100ML (1026ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (1540ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2053ML)
USFDA APPLICATION NUMBER - 200656
DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100...DOSAGE - EMULSION;INTRAVENOUS - 3.3%;29MG/100ML;9.8GM/100ML;96MG/100ML;174MG/100ML;239MG/100ML;147MG/100ML;3.9GM/100ML (2566ML)
USFDA APPLICATION NUMBER - 200656
Digital Content
DATA COMPILATION #PharmaFlow
Global Sales Information
Market Place
ABOUT THIS PAGE
92
PharmaCompass offers a list of Sodium Glycerophosphate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sodium Glycerophosphate manufacturer or Sodium Glycerophosphate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sodium Glycerophosphate manufacturer or Sodium Glycerophosphate supplier.
PharmaCompass also assists you with knowing the Sodium Glycerophosphate API Price utilized in the formulation of products. Sodium Glycerophosphate API Price is not always fixed or binding as the Sodium Glycerophosphate Price is obtained through a variety of data sources. The Sodium Glycerophosphate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A alpha-glycerophosphoric acid, (DL)-isomer manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of alpha-glycerophosphoric acid, (DL)-isomer, including repackagers and relabelers. The FDA regulates alpha-glycerophosphoric acid, (DL)-isomer manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. alpha-glycerophosphoric acid, (DL)-isomer API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of alpha-glycerophosphoric acid, (DL)-isomer manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A alpha-glycerophosphoric acid, (DL)-isomer supplier is an individual or a company that provides alpha-glycerophosphoric acid, (DL)-isomer active pharmaceutical ingredient (API) or alpha-glycerophosphoric acid, (DL)-isomer finished formulations upon request. The alpha-glycerophosphoric acid, (DL)-isomer suppliers may include alpha-glycerophosphoric acid, (DL)-isomer API manufacturers, exporters, distributors and traders.
click here to find a list of alpha-glycerophosphoric acid, (DL)-isomer suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A alpha-glycerophosphoric acid, (DL)-isomer DMF (Drug Master File) is a document detailing the whole manufacturing process of alpha-glycerophosphoric acid, (DL)-isomer active pharmaceutical ingredient (API) in detail. Different forms of alpha-glycerophosphoric acid, (DL)-isomer DMFs exist exist since differing nations have different regulations, such as alpha-glycerophosphoric acid, (DL)-isomer USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A alpha-glycerophosphoric acid, (DL)-isomer DMF submitted to regulatory agencies in the US is known as a USDMF. alpha-glycerophosphoric acid, (DL)-isomer USDMF includes data on alpha-glycerophosphoric acid, (DL)-isomer's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The alpha-glycerophosphoric acid, (DL)-isomer USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of alpha-glycerophosphoric acid, (DL)-isomer suppliers with USDMF on PharmaCompass.
A alpha-glycerophosphoric acid, (DL)-isomer CEP of the European Pharmacopoeia monograph is often referred to as a alpha-glycerophosphoric acid, (DL)-isomer Certificate of Suitability (COS). The purpose of a alpha-glycerophosphoric acid, (DL)-isomer CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of alpha-glycerophosphoric acid, (DL)-isomer EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of alpha-glycerophosphoric acid, (DL)-isomer to their clients by showing that a alpha-glycerophosphoric acid, (DL)-isomer CEP has been issued for it. The manufacturer submits a alpha-glycerophosphoric acid, (DL)-isomer CEP (COS) as part of the market authorization procedure, and it takes on the role of a alpha-glycerophosphoric acid, (DL)-isomer CEP holder for the record. Additionally, the data presented in the alpha-glycerophosphoric acid, (DL)-isomer CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the alpha-glycerophosphoric acid, (DL)-isomer DMF.
A alpha-glycerophosphoric acid, (DL)-isomer CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. alpha-glycerophosphoric acid, (DL)-isomer CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of alpha-glycerophosphoric acid, (DL)-isomer suppliers with CEP (COS) on PharmaCompass.
A alpha-glycerophosphoric acid, (DL)-isomer written confirmation (alpha-glycerophosphoric acid, (DL)-isomer WC) is an official document issued by a regulatory agency to a alpha-glycerophosphoric acid, (DL)-isomer manufacturer, verifying that the manufacturing facility of a alpha-glycerophosphoric acid, (DL)-isomer active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting alpha-glycerophosphoric acid, (DL)-isomer APIs or alpha-glycerophosphoric acid, (DL)-isomer finished pharmaceutical products to another nation, regulatory agencies frequently require a alpha-glycerophosphoric acid, (DL)-isomer WC (written confirmation) as part of the regulatory process.
click here to find a list of alpha-glycerophosphoric acid, (DL)-isomer suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing alpha-glycerophosphoric acid, (DL)-isomer as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for alpha-glycerophosphoric acid, (DL)-isomer API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture alpha-glycerophosphoric acid, (DL)-isomer as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain alpha-glycerophosphoric acid, (DL)-isomer and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a alpha-glycerophosphoric acid, (DL)-isomer NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of alpha-glycerophosphoric acid, (DL)-isomer suppliers with NDC on PharmaCompass.
alpha-glycerophosphoric acid, (DL)-isomer Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of alpha-glycerophosphoric acid, (DL)-isomer GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right alpha-glycerophosphoric acid, (DL)-isomer GMP manufacturer or alpha-glycerophosphoric acid, (DL)-isomer GMP API supplier for your needs.
A alpha-glycerophosphoric acid, (DL)-isomer CoA (Certificate of Analysis) is a formal document that attests to alpha-glycerophosphoric acid, (DL)-isomer's compliance with alpha-glycerophosphoric acid, (DL)-isomer specifications and serves as a tool for batch-level quality control.
alpha-glycerophosphoric acid, (DL)-isomer CoA mostly includes findings from lab analyses of a specific batch. For each alpha-glycerophosphoric acid, (DL)-isomer CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
alpha-glycerophosphoric acid, (DL)-isomer may be tested according to a variety of international standards, such as European Pharmacopoeia (alpha-glycerophosphoric acid, (DL)-isomer EP), alpha-glycerophosphoric acid, (DL)-isomer JP (Japanese Pharmacopeia) and the US Pharmacopoeia (alpha-glycerophosphoric acid, (DL)-isomer USP).
